Circulating proteins as biomarkers of response to cancer immunotherapy (Review) [0.03%]
循环蛋白作为癌症免疫治疗反应生物标志物的研究(综述)
Celeste Pinard,Angeline Ginzac,Catherine Abrial et al.
Celeste Pinard et al.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer management; however, durable benefit is observed only in a minority of patients. To overcome the limitations of currently approved tumour tissue‑based biomarkers of response, s...
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways [0.03%]
【校正】肿瘤坏死因子-α在头颈鳞癌中诱导相反信号并分别通过线粒体和非线粒体依赖途径诱导凋亡
Denis Selimovic,Renate U Wahl,Emmanuelle Ruiz et al.
Denis Selimovic et al.
Following the publication of the above article, an interested reader drew to the Editor's attention that a number of western blots in the paper appeared to contain incorrectly assembled data. First, comparing the F. Length (full‑length) Ca...
Published Erratum
International journal of oncology. 2026 Jul;69(1):75. DOI:10.3892/ijo.2026.5888 2026
Research advances in aptamers in the diagnosis and treatment of breast cancer (Review) [0.03%]
乳腺癌诊断和治疗中适配体研究进展(综述)
Liqiang Chu,Yunfeng Xiao,Xinhua Li et al.
Liqiang Chu et al.
Cancer is a malignant disease that threatens human life and health. Among cancer types, breast cancer is one of the most common malignant tumors in women worldwide and ranks among the top cancer types in terms of incidence rate of malignant...
[Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2 [0.03%]
MicroRNA-155通过靶向ARID2促进人类肝细胞癌肿瘤生长〔撤稿〕
Li Zhang,Wei Wang,Xiaobin Li et al.
Li Zhang et al.
Following the publication of the above paper, a concerned reader drew to the Editor's attention that, in addition to concerns about the description of one of the antibodies employed in this study, the immunohistochemical data shown in Fig. ...
METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review) [0.03%]
METTL3在食管癌中的作用：分子机制、亚型异质性及靶向治疗前景的研究进展（综述）
Chunlan Pu,Huan Hu,Hengrui Fan et al.
Chunlan Pu et al.
Esophageal cancer (EC), comprising esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), urgently requires novel targeted therapies. The m6A methyltransferase METTL3 has emerged as a critical epitranscriptomic regul...
Biomarkers for oesophageal squamous cell carcinoma and the role of HPV: Multi‑omics approaches and current evidence (Review) [0.03%]
食管鳞状细胞癌的生物标志物及HPV的作用：组学方法和现有证据（综述）
Limin Zou,Hongzhou Zhao,Jiaying Zhang et al.
Limin Zou et al.
Oesophageal squamous cell carcinoma (ESCC) represents a major global health burden, particularly in regions with high incidence rates, significantly affecting patient quality of life and survival outcomes. Recent advances in multi‑omics te...
[Expression of Concern] AHIF promotes glioblastoma progression and radioresistance via exosomes [0.03%]
[AHIF通过外泌体促进胶质母细胞瘤的进展和放疗抵抗]
Xuejun Dai,Keman Liao,Zhijun Zhuang et al.
Xuejun Dai et al.
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, in Fig. 2E on p. 264, the Transwell invasion assay results shown in the "T98G‑AHIF KD" data panel appeared to potentially cont...
Novel therapeutic strategies for metastatic castration‑resistant prostate cancer: Beyond androgen receptor pathway inhibition (Review) [0.03%]
转移性去势抵抗性前列腺癌的新治疗策略——超越雄激素受体途径抑制（综述）
Yaqin Wang,Yongqiang Xie,Qiang Zhao
Yaqin Wang
Metastatic castration‑resistant prostate cancer (mCRPC) remains a lethal disease due to universal resistance to androgen‑receptor pathway inhibitors (ARPI). Tumor progression is orchestrated by a spectrum of androgen‑receptor‑independen...
RRP9 suppresses hepatocellular carcinoma progression by inhibiting the PI3K/AKT/mTOR pathway [0.03%]
RRP9通过抑制PI3K/AKT/mTOR信号途径抑制肝癌进展
Zhengkang Fu,Man Li,Keshuai Dong et al.
Zhengkang Fu et al.
Ribosomal RNA processing 9 (RRP9) encodes a WD‑repeat domain‑containing protein, which is a potential carcinogenic biomarker for various tumors. As a key structural component of small nucleolar ribonucleoproteins, RRP9 serves a key role i...
[Corrigendum] PRIMA‑1 inhibits growth of breast cancer cells by re‑activating mutant p53 protein [0.03%]
[致谢]PRIMA-1通过重新激活突变型p53蛋白抑制乳腺癌细胞的生长
Yayun Liang,Cynthia Besch-Williford,Salman M Hyder
Yayun Liang
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, regarding the immunohistochemical images shown in Fig. 1B on p. 1018, the 'PAb1620/PM 25μM' and 'PAb1620/PM 50μM' data panels ...
Published Erratum
International journal of oncology. 2026 Jun;68(6):68. DOI:10.3892/ijo.2026.5881 2026